Guangdong Kerun Biopharmaceutical Co., Ltd. was established in 2009 and is a national high-tech enterprise integrating bioengineering, pharmaceutical manufacturing, ecological cultivation and animal husbandry, as well as nutritional research and technological collaboration. The company has successfully passed audits and inspections by authoritative agencies including China’s Ministry of Agriculture and Rural Affairs, Australia’s APVMA, and regulatory bodies in Europe and the United States, and has been awarded designations such as “Guangdong Provincial Postdoctoral Workstation,” “Guangdong Provincial Science and Technology Expert Workstation,” “Guangdong Provincial Engineering Technology Research Center for Traditional Chinese Veterinary Medicinal Preparations,” “Guangdong Provincial Specialized, Refined, Distinctive, and Innovative SME,” “Guangdong Provincial Science and Technology‑Based SME,” and “Guangdong Provincial Innovative SME.”
Guangdong Kerun Biopharmaceutical Co., Ltd. was established in 2009 and is a national high-tech enterprise integrating bioengineering, pharmaceutical manufacturing, ecological cultivation and animal husbandry, as well as nutritional research and technological collaboration. The company has successfully passed audits and inspections by authoritative agencies including China’s Ministry of Agriculture and Rural Affairs, Australia’s APVMA, and regulatory bodies in Europe and the United States, and has been awarded designations such as “Guangdong Provincial Postdoctoral Workstation,” “Guangdong Provincial Science and Technology Expert Workstation,” “Guangdong Provincial Engineering Technology Research Center for Traditional Chinese Veterinary Medicinal Preparations,” “Guangdong Provincial Specialized, Refined, Distinctive, and Innovative SME,” “Guangdong Provincial Science and Technology‑Based SME,” and “Guangdong Provincial Innovative SME.”
Guangdong Kerun’s charitable donation helps its hometown fight the epidemic.
2020-02-21
A sudden outbreak of the novel coronavirus struck people with an extremely terrifying and grim visage. A war without smoke quickly erupted across the country, marking the beginning of a nationwide campaign to contain the epidemic.
Even as Guangdong Kerun grappled with numerous challenges in resuming work and production, it remained committed to its social responsibilities, keeping Hubei at heart and lending support to Jingzhou, thereby stepping up to the plate. On February 20, Guangdong Kerun donated RMB 100,000 to the Jingzhou Central Hospital, its hometown hospital, helping to bolster local efforts in the fight against COVID‑19.
Zeng Meiju, the company’s general manager, stated that, as a corporate entity, the company will continue to fulfill its social responsibilities by ensuring safe resumption of work while maintaining rigorous protective measures. It will also closely monitor the epidemic prevention and control situation in its hometown and do everything within its power to contribute to the local community. He expressed confidence that, with united efforts, everyone will surely overcome this pandemic.
Looking forward to your letter.
Add
Qingcheng District, Qingyuan City, Guangdong Province No. 9, Innovation Road, Guangqing Industrial Park
Copyright © 2025 Guangdong Kerun Biopharmaceutical Co., Ltd.
Technical Support:China Enterprise Dynamics Guangzhou